Ambry Genetics Partners RainDance For Diagnostics, Genomics Services
Researchers can utilize the RDT 1000 and Ambry Genetics next generation services to either reduce study time, or to improve study quality by running more samples in the
ReviR Therapeutics has received a rare paediatric disease designation (RPDD) from the US Food and Drug Administration (FDA) for RTX-117, its investigational oral small-molecule therapy for Charcot-Marie-Tooth disease (CMT).